Averhealth, a provider of substance use monitoring and treatment services, and private equity firm Five Arrows, agreed to acquire drug testing services of Treatment Assessment Screening Center, an innovator in the development and implementation of drug testing and behavioral health programs. Financial terms were not disclosed. "This acquisition further advances Averhealth's strategy of uniting people, technology, and science to create and deliver the smartest, most innovative solutions for substance use disorder monitoring and recovery. Together, we will help more individuals safely cross the intersection of criminal justice and healthcare by supporting them to develop lasting coping and refusal skills to new use events, enhancing public safety, and equipping courts and social service agencies with intelligent data and automation," Jason Herzog, Averhealth CEO.